|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 6034 |
FusionGeneSummary for CCNT2_ACMSD |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CCNT2_ACMSD | Fusion gene ID: 6034 | Hgene | Tgene | Gene symbol | CCNT2 | ACMSD | Gene ID | 905 | 130013 |
| Gene name | cyclin T2 | aminocarboxymuconate semialdehyde decarboxylase | |
| Synonyms | CYCT2 | - | |
| Cytomap | 2q21.3 | 2q21.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cyclin-T2SDS-stable vimentin-bound DNA fragment HEF42VIM22cyclin T2acyclin T2bsubunit of positive elongation transcription factor b | 2-amino-3-carboxymuconate-6-semialdehyde decarboxylasepicolinate carboxylase | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | O60583 | Q8TDX5 | |
| Ensembl transtripts involved in fusion gene | ENST00000537343, ENST00000295238, ENST00000264157, | ENST00000356140, ENST00000283054, ENST00000392928, | |
| Fusion gene scores | * DoF score | 2 X 2 X 3=12 | 4 X 2 X 4=32 |
| # samples | 3 | 6 | |
| ** MAII score | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(6/32*10)=0.906890595608518 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: CCNT2 [Title/Abstract] AND ACMSD [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CCNT2 | GO:0019085 | early viral transcription | 21509660 |
| Hgene | CCNT2 | GO:0019086 | late viral transcription | 21509660 |
| Hgene | CCNT2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 15563843 |
| Tgene | ACMSD | GO:0051259 | protein complex oligomerization | 25392945 |
| Tgene | ACMSD | GO:1904985 | negative regulation of quinolinate biosynthetic process | 12140278 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LIHC | TCGA-BC-A10R-01A | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| TCGA | RV | SARC | TCGA-DX-A3M1-01A | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000537343 | ENST00000356140 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| 5UTR-5UTR | ENST00000537343 | ENST00000283054 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| 5UTR-5UTR | ENST00000537343 | ENST00000392928 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| In-frame | ENST00000295238 | ENST00000356140 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| 5CDS-5UTR | ENST00000295238 | ENST00000283054 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| 5CDS-5UTR | ENST00000295238 | ENST00000392928 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| In-frame | ENST00000264157 | ENST00000356140 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| 5CDS-5UTR | ENST00000264157 | ENST00000283054 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| 5CDS-5UTR | ENST00000264157 | ENST00000392928 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135602803 | + |
| 5UTR-3CDS | ENST00000537343 | ENST00000356140 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| 5UTR-3CDS | ENST00000537343 | ENST00000283054 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| 5UTR-3CDS | ENST00000537343 | ENST00000392928 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| In-frame | ENST00000295238 | ENST00000356140 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| In-frame | ENST00000295238 | ENST00000283054 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| In-frame | ENST00000295238 | ENST00000392928 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| In-frame | ENST00000264157 | ENST00000356140 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| In-frame | ENST00000264157 | ENST00000283054 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
| In-frame | ENST00000264157 | ENST00000392928 | CCNT2 | chr2 | 135677461 | + | ACMSD | chr2 | 135655911 | + |
Top |
FusionProtFeatures for CCNT2_ACMSD |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CCNT2 | ACMSD |
| Regulatory subunit of the cyclin-dependent kinase pair(CDK9/cyclin T) complex, also called positive transcriptionelongation factor B (P-TEFB), which is proposed to facilitate thetransition from abortive to production elongation byphosphorylating the CTD (carboxy-terminal domain) of the largesubunit of RNA polymerase II (RNAP II) (PubMed:9499409,PubMed:15563843). The activity of this complex is regulated bybinding with 7SK snRNA (PubMed:11713533). Plays a role duringmuscle differentiation; P-TEFB complex interacts with MYOD1; thistripartite complex promotes the transcriptional activity of MYOD1through its CDK9-mediated phosphorylation and binds the chromatinof promoters and enhancers of muscle-specific genes; this eventcorrelates with hyperphosphorylation of the CTD domain of RNA polII (By similarity). In addition, enhances MYOD1-dependenttranscription through interaction with PKN1 (PubMed:16331689).Involved in early embryo development (By similarity).{ECO:0000250|UniProtKB:Q7TQK0, ECO:0000269|PubMed:11713533,ECO:0000269|PubMed:15563843, ECO:0000269|PubMed:16331689,ECO:0000269|PubMed:9499409}. (Microbial infection) Promotes transcriptionalactivation of early and late herpes simplex virus 1/HHV-1promoters. {ECO:0000269|PubMed:21509660}. | Converts alpha-amino-beta-carboxymuconate-epsilon-semialdehyde (ACMS) to alpha-aminomuconate semialdehyde (AMS).ACMS can be converted non-enzymatically to quinolate (QA), a keyprecursor of NAD, and a potent endogenous excitotoxin of neuronalcells which is implicated in the pathogenesis of variousneurodegenerative disorders. In the presence of ACMSD, ACMS isconverted to AMS, a benign catabolite. ACMSD ultimately controlsthe metabolic fate of tryptophan catabolism along the kynureninepathway. {ECO:0000269|PubMed:19843166}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CCNT2_ACMSD |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CCNT2_ACMSD |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CCNT2 | HEXIM1, RB1, CDK9, BRD4, MEPCE, TERF2, MLLT3, ELAVL1, PKN1, MED26, ELL2, AFF4, SUPT5H, ELL3, CDK6, HEXIM2, H2AFY2, TRIM25 | ACMSD | MAGEA11, CDK20 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CCNT2_ACMSD |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CCNT2_ACMSD |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|